FDA takes application for generic Copaxone by Mylan, Natco

09/15/2009 | Bloomberg

The FDA accepted an abbreviated new-drug application for injectable glatiramer acetate, Mylan and Natco Pharma's multiple sclerosis drug candidate. The product is a generic version of Teva Pharmaceutical Industries' blockbuster drug Copaxone.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO